Virtu Financial LLC Clearside Biomedical, Inc. Transaction History

Virtu Financial LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$0.68 - $1.18 $11,908 - $20,665	17,513 New	17,513 $20,000
Q2 2023 Jul 27, 2023	BUY	$0.97 - $1.48 $32,828 - $50,089	33,844 New	33,844 $38,000
Q1 2022 May 17, 2022	SELL	$1.35 - $2.88 $19,673 - $41,970	-14,573 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$2.72 - $5.72 $39,638 - $83,357	14,573 New	14,573 $40,000
Q3 2020 Dec 11, 2020	SELL	$1.45 - $2.0 $19,267 - $26,576	-13,288 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$1.55 - $2.41 $61,018 - $94,874	-39,367 Reduced 74.76%	13,288 $25,000
Q4 2019 Feb 04, 2020	BUY	$0.62 - $3.4 $25,567 - $140,209	41,238 Added 361.2%	52,655 $153,000
Q3 2019 Nov 20, 2019	BUY	$0.59 - $1.32 $6,736 - $15,070	11,417 New	11,417 $7,000
Q2 2019 Aug 13, 2019	SELL	$0.97 - $1.42 $66,956 - $98,018	-69,027 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$1.1 - $1.74 $17,283 - $27,338	15,712 Added 29.47%	69,027 $95,000
Q4 2018 Jan 16, 2019	BUY	$1.0 - $6.12 $39,962 - $244,567	39,962 Added 299.27%	53,315 $57,000
Q1 2018 May 14, 2018	BUY	$5.57 - $14.28 $74,376 - $190,680	13,353 New	13,353 $143,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.